TAZVERIK
NDC 72607-100, tazemetostat, tablet, film coated, from Epizyme, Inc..
- Product NDC
- 72607-100
- Status
- Listed
- Labeler
- Epizyme, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA211723
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72607-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TAZEMETOSTAT HYDROBROMIDE200 mg/1
Pharmacologic classes
Methyltransferase Inhibitor [EPC]; Methyltransferase Inhibitors [MoA]; Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]; Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72607-100-00 | 72607010000 | 240 TABLET, FILM COATED in 1 BOTTLE (72607-100-00) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7db07b5f-4e22-467c-9c0a-f830b08dbb1d
Use it
Look up 72607-100 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72607-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72607-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.